Chemoinformatics and modeling solutions to optimize your drug candidates. MolDrug (a ProtoQSAR company) is a group specializing in the design and optimization of molecules through Machine Learning-powered chemoinformatics and structural bioinformatics. Our models allow for the prediction of molecular properties (QSAR) and detailed interaction analyses (molecular modelling). We work with all types of compounds, including small molecules, peptides, nanomaterials, mixtures... Our tools allow for the prediction and assessment of physicochemical, biological, pharmacological, and/or (eco)toxicological properties of substances with an array of advantages: - faster results - saving money and resources - reduce animal testing (3 Rs) - regulatory validity (REACH, …

66 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Bioceltix is changing the veterinary therapy standards. We develop innovative biopharmaceuticals based on stem cells. Bioceltix is a Wrocław-based and internationally oriented biotechnological company developing innovative, both stem cells and secretome based products, for companion animals. Our flagship technology for manufacturing biopharmaceuticals for veterinary use utilizes the therapeutic potential of allogeneic stem cells (one donor – many recipients). Owning a GMP production facility, we provide single technology for several species, diseases, and routes of administration. Our cutting-edge approach will allow the product to be batch-produced and ready for off-the-shelf sale. The veterinary medicines, based on the immunomodulatory mechanism of action …

231 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We CARE. We CREATE. We DELIVER. At LTS, our purpose drives everything we do: We CARE for patients, our partners , employees and communities, we CREATE innovative drug delivery solutions, and we DELIVER high-quality products to global markets with an exceptional track record in commercial manufacturing. As a global CDMO, we offer end-to-end development and manufacturing services for pharmaceutical and biotech companies. Our technology portfolio spans transdermal patches, oral thin films, nasal and sterile (drug delivery systems) dosage forms , wearable drug delivery devices as well as microneedle array patches. With over 40 commercial products and 50+ active development programs, …

131 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

less complexity. more biology. At Chromodynamics, we are on a mission to deliver instruments that eliminate guesswork from drug development and prescription. Our unique technology allows for an enormous improvement in speed, efficacy, and cost with which exciting new treatments like immunotherapy are developed. We have been recognised as one of the most promising startups in the Eindhoven Brainport region and are expanding our team to ramp up our product development. Imaging systems, Multispectral imaging, Real-time analysis, Chemical imaging, Spectroscopy, Scientific instruments, Contract research, and Data analysis

931 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Pioneers in complex formulation · Ascil Biopharm is a clinical-stage biotechnology company specializing in innovative drug delivery solutions. We operate as a CDMO, fully equipped for early-stage drug product development, with a GMP facility for clinical batch manufacturing, (aseptic process and terminal sterilization) to fill various containers (e.g. vials, syringes). Our capabilities extend to formulation, device, and analytical development. · Our proprietary Controlled-Release Formulation (CRF) platform technology, is designed to improve the Phy-Chem properties of APIs and excipients under injection conditions, enabling the development of ready-to-use (RTU) controlled-release formulations and ultra-high concentration (UHC) drug products. · Our expertise covers a …

141 similar entities Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

Global experts in nanotechnology and drug particle engineering Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services. Nanoform’s capabilities include GMP manufacturing, and its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications.

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Streamlining nanoparticle formulation to release the full power of RNA-LNPs and nanomedicines. InsideTx streamlines RNA-LNP formulation from screening to manufacturing. Founded at the intersection of microfluidics and biotechnology, we build formulation platforms that cover the full RNA-LNP & nanomedicine development pipeline — so researchers can focus on the science, not the process. TAMARA is our all-in-one R&D platform for nanoparticle formulation. It handles everything from early screening to preclinical in-vivo studies in a single instrument (0.2–30 mL), with zero formulation losses, reusable microfluidic chips, and two mixing geometries on one reversible chip. As one of our users put it: "I'm …

85 similar entities Type: Startup Activities: manufacturing nanotech deeptech biotech Technologies: Synthetic Biology SaaS

You have the motivation, we have the rest! We are developing a new form of administration of active ingredients by vaporization. We operate in respiratory health around smoking cessation mainly and related diseases such as COPD/Asthma as well as pain management. Our development focuses on a vaporization medical device coupled with liquid medicinal formulations. Biotechnology, CBD, Health, Pharmaceuticals, vaporization, SEDEM, respiratory health, smoking cessation, COPD, and pain management

106 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Mark Smith and Stephen Cork were appointed Administrators on 21 August 2024, and act without personal liability. Destiny Pharma is a clinical stage, innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections. Its pipeline has novel microbiome-based biotherapeutics and XF drug clinical assets including NTCD-M3, a Phase 3 ready treatment for the prevention of C. difficile infection (CDI) recurrence which is the leading cause of hospital acquired infection in the US and also XF-73 nasal gel, which has recently completed a positive Phase 2b clinical trial targeting the prevention of post-surgical staphylococcal hospital infections …

236 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Pulmonary drug delivery with near 100% efficiency DP Innovations Ltd is a privately held healthcare company based in Woodside, CA. The main activity of the company is the development of an innovative pulmonary drug delivery system called SPRIN. SPRIN provides pharmaceutical companies with an alternative delivery system to needle injection for high-precision drugs, such as insulin, gene therapy, antivirals, etc.

61 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

HELPING CREATE A HEALTHIER WORLD THROUGH EXCELLENCE As CDMO (Contract and Development Manufacturing Organization), BePharBel Manufacturing contributes to improve the health of all by supplying our pharma partners: - a genuine end-to-end development and manufacturing solution - that facilitates and accelerates drugs availability for patients. Our main activities are: 1) CDMO BePharBel Manufacturing provides an integrated end-to-end solution for the development and manufacturing, under European GMP conditions, of drugs (small molecules and antibiotics) and medical devices. Our expertise field is the development of new formulations and drug formulations over more than 10 different sterile and non-sterile galenic forms (injectables, powder …

102 similar entities Type: Startup Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

Where Molecule Becomes Medicine — First-Time-Right | Solid-State, Preformulation, Formulation & GMP Manufacturing Crystal Pharmatech is a science-led CRO/CDMO for small molecule drug development — from solid form selection and preformulation through formulation development and GMP clinical supply. Since 2010, we have supported more than 4,000 compounds for pharmaceutical and biotechnology partners worldwide. We start with solid form science. Polymorph, salt, and cocrystal screening, crystallization process development, and developability assessment establish — from data rather than assumption — whether a molecule will succeed as a crystalline solid or requires an enabling formulation. Our containment capability extends this work to highly …

150 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

Innovative Manufacturing Services (IMFS).

176 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Nano Life Sciences Cementic, is biotech startup (Paris, France/Palo Alto, USA). Specializing in cutting-edge nano-biotechnology solutions with a focus on the dental field. Medtech, Biotech, Dental, Orthopedics, Nanotechnolgies, Stem cells , and Liposomes

118 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Bringing People & Ressources Together The creation of Genbiotech, a spinoff of the Laboratoires Genévrier results of 15 years of strategic involvement in biotechnological research with one goal: to improve the quality of life of patients in the field of rheumatology, dermatology and aesthetic. We believe that tomorrow medicine needs to be dedicated and targeted to patients. We aim to improve existing treatments by using non invasive processes allowing local and sustained administration of biological and active molécules. The company, incepted in 1998, has currently a staff of 11 people and is located in Sophia Antipolis (South of France). For …

633 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

From research to patients: safer, smarter, faster. 3Biotech provides Innovative solutions continuously to challenge, support and accelerate the manufacturing of safe drug candidates. We are your colleagues, partner for the Chemistry, Manufacturing and Control (CMC) to succeed in your project and mission to create a new future and impact patient outcomes. Our Three Pillars are: 1.Safety 2. Efficacy 3. Manufacturing These are our drivers to secure all steps from the research to the first in human stage with the most innovative project strategy and plan of execution. We have implemented a human and customer centric organization to provide the best …

124 similar entities Type: Startup Activities: biotech deeptech fintech manufacturing regtech Technologies: Synthetic Biology

Innovative Process Solutions IPSOMEDIC is a pharmaceutical development company, specializing in innovation in the manufacturing of active pharmaceutical ingredients (APIs). Our objective is to give countries the possibility to reach their pharmaceutical independance. We design tailor-made processes for all stages of industrial production, to become cost efficient, environmental-friendly, and safe: - Continuous chemical reaction - Continuous purification - Continuous crystallization Innovation, Chemical processes, drug substance, and Continuous processes

89 similar entities Type: Startup Activities: manufacturing industry 4.0 Technologies: Synthetic Biology

Built around safe-by-design concept, Adjuvatis is committed for innovative formulations to improve pharmaceuticals Adjuvatis, a French startup in biotechnology, develops innovative safe-by-design delivery systems to help laboratories and pharmaceutical companies in vaccine formulation as adjuvants and in drug delivery as vectors for oncology, dermatology, infections, etc. Our first technology, called i-Particles®, is based on 200 nm-diameter particles composed of poly-lactic acid only (any surfactant and solvents) for formulation of hydrophobic molecules in the particle core and surface functionalization of peptides. Our second technology, i-LipoP®, consists in i-Particles® covered by lipidic bilayers at their surface for vectorization of nucleic acids and …

100 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Nanomaterials as Nanomedicines: let's play collective! SUPERBRANCHE : Nanomedicine as a breakthrough to treat cancer We bring answers to the following issue: intratumoral injection of nanomaterials implying both accessibility and detection of the tumor beforehand. We position ourselves as a producer dedicated to the synthesis of architectured nanomaterials as simple as possible and of controlled size. Our modular technology platform presents both therapeutic and diagnosis applications. It consists in a magnetic nanoparticle coated by a tailor made branched architecture. Thanks to their optimized shape and stability, our compounds are well tolerated and can be administered intravenously, thus helping to the …

78 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

OneHealth/AI DeepTech discovering patentable mixes of natural ingredients preserving health and optimizing bioprecesses Alphanosos, a Green One-Health DeepTech company, uses its own Artificial Intelligence algorithms to discover, develop and market active ingredients and products based on blends of extracts from non-pharmaceutical ingredients, in particular edible plants. These active mixtures, some of which are already patented in 15 countries for their antimicrobial activities, are intended for the animal hygiene, dermocosmetics, food preservation and cosmetics sectors, bioprocess optimization and in the longer term, for functional foods and disease treatments. The company began its Research and Development (R&D) activities in mid-2015 and is …

224 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I.

Regenerative Medicine - Growth Disregulation - Oncology REGULAXIS is a French innovative biotechnology company based at BIOCITECH the technology park of life science of Paris North area. The company is engaged in the research, development and licensing of innovative synthetic molecules for use in human therapies. Its mission is to grant licenses of innovative molecules in a pharmaceutical company after the establishment of a phase II clinical record. REGULAXIS leads its R&D on its own premises, particularly in regard to biochemical and biological experiments, and keeps the mastery of the chemical synthesis of its therapeutic molecules. The company develops its …

140 similar entities Type: Startup Activities: biotech healthtech Technologies: Synthetic Biology

The Medicine Maker celebrates the people, processes and vision that bring new drugs and biologics to market. The development and manufacture of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to bring this group into the limelight and, in doing so, to integrate the entire process, from the registration of an Investigational New Drug (IND) or Biologics License Application (BLA) through to the market launch of new therapies, and beyond. pharmaceutical , biopharmaceutical, bioprocess, upstream, downstream, formulation, drug delivery, and dosage form

63 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Advanced Nanotechnologies A nanobiotechnology and smart polymers company. The company is committed to products for several engineering the biomedical sectors, with an emphasis on tissue engineering, drug delivery and functionalized electrospun nanofibers. Nanofaber Srl is the exclusive distributor on the Italian soil of Bioinicia Fluidnatek Slu, leader company in Europe regarding the electrospinning equipment and services. Through its high-specialized division, Nanofaber can offer to its clients premium equipment, services and commercial/technical assistance on the electrospinning and electrospraying technology. nanofibers, SERS, oncoproteins, and nanomechanics

58 similar entities Type: Startup Activities: nanotech deeptech Technologies: Synthetic Biology

Within the Chugai Pharmaceutical Group, Chugai Pharmaceutical Industries is responsible for development and production functions. We receive the manufacturing process for investigational drugs and products from Chugai Pharmaceutical, create methods and systems that can actually be produced at our factories, and perform quality control and evaluation. In this way, we play an essential role in turning medicines from the idea stage into real products that benefit patients. Pharmaceuticals, new drug development, global companies, biopharmaceuticals, small and medium molecule drugs, pharmaceutical manufacturing, production technology, IT engineers, engineers, quality control, and quality assurance

80 similar entities Type: SMB Activities: it services Technologies: Synthetic Biology

Building molecule from Idea! ATLANCHIM PHARMA is a chemistry-based CRO (Contract Research Organization) conducting confidential custom synthesis of complex molecules tailored to customer specifications. Our team provides multi-step organic synthesis from a milligram to several gram scale. CRO, Custom synthesis, Chemistry, Research & Development, Organic chemistry, Medicinal chemistry, Reproduction services, Stable isotope labeling, Organic synthesis, Heterocycle synthesis, Carbohydrate chemistry, Peptide synthesis, Impurety synthesis, and Hit to lead

62 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Bio sourced materials

MediPharm Labs was created in 2015 by a handful of industry experts in Ontario. With the medicinal benefits of cannabis firmly established – and with a global patient market demanding quality cannabis oil – MediPharm Labs was born. While initially exploring options to cultivate cannabis plant, MediPharm Labs came to recognize the opportunity for a select focus on cannabis concentrates. MediPharm Labs set out to master this area of production, and rely on the many cultivating experts to provide quality raw materials. In 2016, MediPharm labs submitted an application to Health Canada for approval to distribute medicinal cannabis oil. Proudly, …

58 similar entities Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

Laboratory for the Synthesis and Isolation of Bioactive Molecules (Faculty of Pharmacy, University of Tours) Development of new methodological tools for the synthesis and functionalization of heterocycle entities Synthesis and isolation of molecules for anti-infectious and anti-cancer purposes Innovation in extractive chemistry: Centrifugal Partition Chromatography, Deep Eutectic Solvents Organic Chemistry, Extraction of Natural Products, and Medicinal Chemistry

148 similar entities Type: Startup Activities: deeptech biotech Technologies: Bio sourced materials

Antineo aims to accompany customers in the preclinical development of novel anticancer agents. We provide services and strategic advice for preclinical development, optimal choice of in vitro and in vivo models as well as strategic input on potential indications to target in the therapeutic landscape. Développement préclinique, in vitro, ex vivo, in vivo, Preuve de concept, Expertise scientifique en pharmacologie, and Modèles à façon

223 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Ultra-performance materials for various industries, from electronics, automotive and aerospace to biotech/medtech INCAPTEK Sàrl is a start-up from Switzerland developing technologies to produce a range of ultra-performance materials, from self-activating fire-extinguishing materials to ultra-low-k materials, for various industries, from electronics, automotive and aerospace to medtech. We push technological boundaries by offering ultra-performance. We also design smart microencapsulation solutions for cosmetics, food & beverages, etc. as well as highly innovative materials for controlled and targeted drug delivery for biotech/medtech. We deliver drugs at the right place, in the right dosage, and at the right time, bringing treatment outcomes to the next …

84 similar entities Type: Startup Activities: deeptech nanotech Technologies: Synthetic Biology New Materials

Smartox Biotechnology is specialized in peptide research and manufacturing Smartox Biotechnology is specialized in peptide research and engineering. Peptide synthesis, physiology, pharmacology, neuroscience, ion channel research, toxin, venomous animals, and screening library

297 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Creation and implementation of innovative therapeutic solutions derived from cannabinoid biomolecules. Since the entry into common law of medical cannabis in September 2023, the development of new drugs has been at the center of the pharmaceutical industry's concerns. Chenevia is a French Biotech startup, financed by Breton investors, subsidized by the Brittany Region, supported by Crédit Agricole via the Village by CA Morbihan accelerator and active member of Santé France Cannabis (privileged consultant to the Government on the regulation of medical cannabis). The 3 co-founders have skills combining technique, pharmaceutical expertise and compliance with regulatory constraints. We are committed to …

140 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

We were made for this 53Biologics is a end-to-end biologics CDMO built to keep progress moving. By combining scientific expertise, integrated in-house capabilities and a collaborative way of working, we enable confident decision-making as biologics programs evolve. We support your biologic from early development to commercialization. With USP and DSP development, GMP manufacturing, quality control and fill-finish connected under one roof, we reduce handoffs, protect continuity and help clients grow without disruption. We were made for this. Biopharmaceuticals , CDMO, pDNA, Recombinant Protein, GMP, Drug Development, Microbial Manufacturing, Cell Banking, and GMP Manufacturing

353 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Innovating to Enhance Quality of Life Fitabeo Therapeutics is a clinical-stage specialty pharmaceutical company that develops and commercialises a differentiated portfolio of innovative medicines focusing on indications where existing treatments are inadequate for the target population. It deploys breakthrough technologies to develop medicines that enable patient autonomy, decentralise patient care and provide superior health outcomes. Oral Thin Films, Geriatrics, Paediatrics, Patient autonomy, Equitable Access, Innovative medicines, Medication adherence, Central Nervous System, Women's Health, and Neurology

616 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

🔬 NextGen Functional Ingredients. Protein-based microencapsulation for probiotics, bioactives and flavours. Green Nanotechnology NUCAPS@ is a consortium comprised by two Pharmaceutical companies (Laboratorios Cinfa and IDIFARMA), a Food Technological Center (CNTA) and the University of Navarra. T his consortium has developed new solutions based on the use of Food proteins (GRAS) as casein, zein or soya for the oral delivery and controlled release of drugs/actives and/or microorganisms. Nanotechnology, Encapsulation, Nanoencapsulation, Microencapsulation, Food, Nutrition, Cosmetic, Farmaceutic, Pharmaceutical, Health, Probiotics, Bioactives, Flavourings, and Biomolecules

65 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology Bio sourced materials

To make disease-modifying treatments available to patients with serious or life-threatening conditions Medibiofarma S.L is a clinical-stage biotechnology company founded in 2016 by a group of professionals with extensive experience in Drug Discovery in the pharmaceutical industry. We aim to generate innovative and high quality research programs based on the modulation of clinically validated therapeutic targets for the treatment of cancer and non-cancer diseases. Medicinal Chemistry, in vitro Pharmacology, Drug Discovery and Development, IP generation, IBD (Colitis, Crohn), Oncology, CNS, and Synaptopathies

630 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We Craft Care SOMAÍ is a leading EU-GMP European vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceutical extract portfolio. At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine. SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that …

62 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development. biotechnology, pharmaceuticals, drug discovery, preclinical research, bioanalytical development services, bioinformatics, systems biology, proteins, genomics, proteomics, autoimmune disorders, regulatory studies, medicinal chemistry, agrochemical, industrial chemistry, and assay development&screening

514 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

From Nature to market Who we are : Greenpharma is a CRO SME of 12 people, specialised in natural compound studies for cosmetic, food and pharmaceutical industries. Built around an innovative technological platform, Greenpharma succeeded to gather expertise in wide and complementary fields such as chemoinformatic, pharmacognosy, medicinal & analytical chemistry, pilot scale extraction and formulation. This has led to a unique know-how in natural compound & extract selection, extract purification, metabolite measurement, homology modelling, virtual screening (e.g. SelnergyTM), lead optimisation, ADMET prediction and database building. Greenpharma approach has led to several patents on bioactive (natural or synthetic) molecules and …

72 similar entities Type: SMB Activities: biotech deeptech Technologies: Bio sourced materials

Enzymatica AB is a Swedish life science company that develops and sells medical devices for infection-related diseases. The products are based on a barrier technology that includes marine enzymes. The Company’s first product is ColdZyme®, a mouth spray which protects against common cold, can help shorten the duration of a common cold if used at an early stage of the infection, alleviates common cold symptoms and soothes sore throat. Our head office is in Lund, Sweden, but we also have an office in Reykjavik, Iceland. For product info, please visit at www.coldzyme.co.uk. Cold and Flu, Enzyme (trypsin), and Barrier technology

219 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

We are your responsive, reliable, and resourceful CDMO Partner. Streamline your biomanufacturing programs with Cytovance Biologics! Born from a decades-long history in drug development, we believe in creating a healthier world where every biologic’s path to commercialization is advanced by a CDMO partner that delivers ingenuity end-to-end. Whether your large molecule product needs the flexibility of a customized approach or the efficiency of a predetermined platform process, Team Cytovance has the deep expertise in microbial and mammalian expression systems to support your scale-up at every stage. From early needs like cell line development and strain selection to cGMP manufacturing for …

192 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Transforming lives with groundbreaking treatments Coultreon Biopharma's mission (formerly Onco3R Therapeutics) is to develop life-changing medicines for patients affected by chronic inflammatory diseases of high unmet medical needs. The team is leveraging their knowledge and expertise to bring transformative innovations to patients suffering from auto-immune diseases. In this field, there is an urgent need for more convenient oral drugs that can offer greater efficacy with a better safety profile. Drug Discovery, Drug Development, Immunology, Biotech, and R&D

826 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Your local champion and alternative partner Newbury Pharmaceuticals was founded in 2020 by Swedish Karl Karlsson. We are rapidly growing and offer a product portfolio of specialty pharma medicines with focus on the Scandinavian markets. The portfolio strategy includes niche and value-added small molecules, products based on peptide technology as well as biosimilars in a variety of therapeutic categories. The portfolio consists of pharmaceuticals from several therapeutic areas with oncology, rare diseases and neurology representing more than 70 percent. The company was listed on Nasdaq First North, February 2022.

98 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Complex APIs made in Hungary. Patriapharma is the international commercial partner of CF Pharma, Hungary, and draws on the pharmaceutical API development and manufacturing capabilities and extensive experience of its partner, whose R&D team maintains a highly specialized development pipeline. Pharmaceuticals and API-development

43 similar entities Type: Startup Activities: biotech Technologies: SaaS

Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry

535 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We’re using ground-breaking cell technologies to revolutionise global food production - starting with pork Uncommon Bio began with cell-based meat and pioneered RNA delivery innovations, which evolved into their most recent spin out which is focusing on changing medicine through multi-targeting. Their polysaccharide-based delivery platform enables multi-pathway cell programming, offering a safe, efficient and scalable alternative to multi-target therapies. The company is initially targeting severe lung diseases like idiopathic pulmonary fibrosis and is backed by industry leaders from BioNTech and top investors, including Sam Altman, Balderton, Lowercarbon, and Redalpine. science+art, biotech, mRNA, IPF, Pulmonary fibrosis, and delivery

561 similar entities Type: Startup Activities: biotech deeptech foodtech Technologies: Synthetic Biology

We develop, optimise and distribute innovative pharmaceutical products that offer a unique solution Who we are: Green Park Pharma UK Ltd. is a pharmaceutical company specialising in innovative drug delivery formulations. Our products address a significant market need across major global markets where the team has successfully operated. Our mission: Our mission is to develop, optimise and distribute innovative pharmaceutical products that offer a unique solution for unmet patient needs across all major global markets. Learn more about us and get in touch

282 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

Zerion Pharma is a pharmaceutical company transforming the landscape for formulation of poorly soluble drugs Zerion is a pharmaceutical company transforming the pharmaceutical landscape for formulation of poorly soluble drugs that are currently not reaching their therapeutic potential. Through the use of our proprietary formulation platform, we aim to develop new treatment options for patients across all small molecule therapy areas. We are focused on improving existing drug products by building an internal pipeline, while partnering with originators to enable their early stage drug molecules, striving to improve the lives of patients around the world. Pharmaceuticals, Formulation, and Drug delivery

184 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Curida is a Contract Development and Manufacturing Organization for Pharmaceuticals, based in Norway. We are building on more than 40 years of experience and offer premium quality manufacturing to international pharma companies. Curida has core competency on sterile and aseptic manufacturing of liquid pharmaceuticals. Our core technologies are blow-fill-seal (BFS) and nasal spray. We work with companies ranging from small biotech to Big Pharma. We have a lean and flexible organization that will, enabling a strong partnership with our customers. Pharmaceuticals, Nutraceuticals, Dietary Supplements, Blow Fill Seal, Nasal Sprays, Liquid Pharmaceuticals, Sterile Production, and Stability Studies

221 similar entities Type: Startup Activities: deeptech manufacturing

Novel small-molecule drugs in immunology, fibrosis and women health Clinical-stage biotech company founded by serial entrepreneurs and owned by private & institutional investors. Discovery and development of new chemical entities with strong IP and worldwide rights targeting indications with high unmet medical need in immunology, fibrosis and women health. Medicinal Chemistry, in vitro Pharmacology, Drug Discovery and Development, Inflammation and autoimmune diseases, IP generation, IBD, Ulcerative Colitis, Crohn's disease, Fibrosis, and Uterine fibroids

346 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

🌿 Green nanoparticles for laser-based therapy Torskal is an early clinical-stage French biotech company specializing in green nanomedicine and laser-based therapies. The company develops eco-friendly gold nanoparticles produced through sustainable synthesis technologies for applications in oncology and women’s health. Its pipeline includes three lead programs: NT1 for skin cancer, NT2 for gastrointestinal (GI) cancers, and NT3 for endometriosis, leveraging nanoparticle-mediated laser therapy approaches Nanotechnology, Nanomedicine, Biotechnology, Nanotheranostics, Nanoparticles, Gold Nanoparticles, Cancer Research, Green Nanotechnology, and laser

82 similar entities Type: Startup Activities: nanotech biotech deeptech Technologies: Synthetic Biology

Global Leaders in Mammalian Cell Line Development KBI Biopharma and Selexis SA are consolidating operations as one organization under the KBI Biopharma name. This streamlined approach supports customers in accelerating drug development and manufacturing, creating greater flexibility, efficiencies, and a simplified partner experience. You can follow us on the KBI Biopharma page to stay up-to-date on the latest news, events, and happenings. Cell Line Development, HTS, Cell Line Engineering, Contract Biological Services, Stable Cell Line Development, Cell Engineering, Variant Screening, Research Cell Banks, Monoclonal Antibodies, Whole Genome Sequencing, Bispecific Antibodies, CDMO, Monoclonality Assessment, Biotechnology, Biosimilars, Cell line engineering, Genetic engineering, …

589 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients Delivering local-acting immunotherapies to patients ATMP, Gene Therapy, Drug development, Clinical trials, GMP, IBD, Wound treatment, Scar, Topical, Oral, Research, Science, Immunology, Immunophysiology, microbiology, Applied microbiology, Regulatory excellence, Skin, Diabetes, IBD, Cysticfibrosis, SAVI, colitis, Cystic fibrosis, and Inhalation

646 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Better and cheaper medicine through porous silica Nanologica is a Swedish nanotechnology company, world-leading in the development of nanoporous silica particles for purification by chromatography. A proprietary production method enables the company to create supreme products by precisely controlling the shape, size, porosity, and surface properties of silica particles. Nanologica provides products of high-quality silica used in the purification of peptide drugs such as insulin and GLP-1 analogues. These products can contribute to lower costs and increase productivity for pharmaceutical manufacturers, which can increase the availability of cost-effective medicines and give more people around the world access to vital treatment …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Europhartech, a company of the Dômes Pharma group Production site of the Dômes Pharpe Europhartech Group is also CMO (Contracting Organization contract) for the human and veterinary pharmaceutical industry. Specialized in clinical lots, the production of dry forms and non -sterile liquid forms for human and veterinary use as well as in food supplements, additional food and medical devices. Europhartech also has solid expertise from Princeps, ATU/AMM Hospital and EHPAD Unit Bud, PDA, Generic and Nutraceutic. Europhartech is a subsidiary of the pharmaceutical group Dômes Pharma specializing in animal health and present in human health since 1992. Laboratory approved by …

206 similar entities Type: SMB Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

Centre d'Etudes Biologiques et Pharmaceutiques OUR MISSION: Provide analytical support for all product development phases (human & veterinary medicines + Medical Device) with: Consulting and expertise Formulation development support Analytical method development and validation Stability studies QC testing Veterinary pre-clinical and clinical studies Analyse pharmaceutique, Pharmaceutical analysis, Contract Research Organization (CRO), Développement analytique, Contrôle qualité pharmaceutique, Quality control (QC), Method development, Analytical method validation, ICH guidelines, ICH Q2 / ICH Q14, Validation analytique, Transfert de méthodes, Biopharmaceuticals, Small molecules, sterile products, Vaccins, Stability studies, Regulatory affairs, GMP compliance, GLP compliance, CCIT (Container Closure Integrity Testing), Extractables & Leachables, Elemental impurities …

135 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

The natural solution for drug delivery DelSiTech is a drug delivery and drug development company based in Turku, Finland. DelSiTech has developed a unique proprietary technology making it a world leader in advanced biodegradable silica-based drug delivery. The technology has successfully been applied to the controlled release of small molecules, biopharmaceuticals and viral vectors with a focus on parenteral and local administration. We can work with you from early feasibility testing to clinical proof of concept; the technology can also be licensed to industry partners. With the DelSiTechTMSilica Matrix, we can create novel products, provide alternative administration opportunities, and extend …

86 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

A BOUTIQUE CDMO DEDICATED TO SMALL QUANTITIES APIs. Founded in 2000, Diverchim is a Small Molecule Drug Substance CDMO that specializes in complex chemistry. Diverchim offers premium services for the development and the manufacturing of small quantities APIs, from early phases to commercial. Our customers include pharma companies and emerging Biotechs involved in developing New Chemical Entities. We have a strong focus on high added-value APIs (rare diseases and orphan drugs, radiopharmaceuticals). Our capabilities include various cGMP manufacturing suites: small scale (mg to dozens of grams), kilolabs (up to a few kilos) and pilot plant (dozens of kilos). Drug Discovery …

127 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

CRO specialized in pharmaceutical drugability for research Expertise in Human and Animal health solid form characterization and formulation development. We deliver both experimental support and consulting services to biotechnology and pharmaceutical companies, not-for-profit organizations and complementary CROs. We are member of the association AFSSI, 1st French research center in Life Sciences, as a founding member and member of the board of Directors. Since March 2019 Joel Vacus, Drugabilis CEO & CSO, is vice-President of AFSSI. https://www.afssi.fr/ Feel free to contact us in order to exchange about your preclinical drug development! contact@drugabilis.com Lead optimization, Formulation, and Physical form optimization

164 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Abzena is the leading integrated bioconjugate & complex biologics CDMO+CRO, focused on rapidly moving medicines forward. Abzena is the leading end-to-end bioconjugate, ADC, and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, …

203 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

Starpharma is a global biopharmaceutical company and a world leader in the development of dendrimers. Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for respiratory viruses, DEP® drug delivery and VivaGel®. Medical Devices, Pharmaceuticals, and Dendrimer Drug Delivery

99 similar entities Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology

Innovating to Disrupt Cancer Treatment Genoscience Pharma is a French biotech company developing unique small molecules in Oncology. This is the first clinical stage company ever with unique lysosomotropic agents assessed in global clinical trials. For more information, please visit our website, or call us +33 4 91 26 99 50. Liver, Oncology, Clinical Development, Preclinical Development, Discovery, Research & Development, Intellectual Property, Drug Development, and Small Molecule

634 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Aureus Sciences focuses on providing solutions to the needs of pharmaceutical and biotech companies to leverage information and knowledge as a decision making tool and to increase the speed and efficiency of their drug discovery and development process. Over the course of 10 years and with a significant investment, the Company has developed a unique Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases. Using this platform the Company provides best-in-class, scientific databases and associated software applications for use by researcher involved in the drug discovery and development process.The company's range of products includes …

150 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Cocoon Biotech, Inc., was founded in 2013 to bring the freedom of living a healthy productive life to patients worldwide. Cocoon Biotech is developing a drug-delivery platform based on formulations of fibroin, a protein derived from the cocoon of the silkworm (Bombyx mori). Recent advances in our understanding of fibroin biochemistry has allowed expansion of the versatility of the material into alternate physical formats such as hydrogels and implants loaded with active drug substances. Cocoon is leveraging silk fibroin as a novel biomaterial for the stability and delivery of therapeutics across human health and animal health. Cocoon’s first products are …

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Mango Materials develops methane-to-PHA biomanufacturing technology for industrial partnerships and licensing. YOPP® products and commercial applications --> MadeWithYOPP.com bioplastics, methane, and biomanufacturing

124 similar entities Type: Startup Activities: biotech deeptech Technologies: New Materials

Unlock the potential of your drug with our expertise in Transdermal and complex Injectable product development Nemaura Pharma is a private specialist biotech company who have developed several advanced versatile skin drug delivery systems. Our technologies have been designed with clinical needs in mind and are all minimally invasive and very cost-effective. We are strategically positioned to work with global pharmaceutical companies, as well as new biotechnology companies, to successfully bring both new and old drugs to patients in superior delivery formulations and systems. Founded in 2005 Nemaura has its headquarters and laboratory facilities in the United Kingdom at the …

172 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Science Driven Development and Analytical Support - From Early Development to Commercialization. Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large …

257 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Powering the future of medicine® We support the advancement of cell and gene therapies through our portfolio of cytokines and media supplements, along with a comprehensive suite of manufacturing services—including the production of proteins, media and buffers, and transfection and transduction reagents. We ensure your raw materials are as innovative as your therapies. GMP cytokines, Crypreservation media, Hemaotopietic and Mesechymal Cells and sources, Sterile Fill & Finish, Media & Buffers, Transfection Reagents, Human Plasma Derived Products, and Growth Factors

181 similar entities Type: SMB Activities: deeptech manufacturing biotech Technologies: Synthetic Biology

Innovative therapies and unique solutions - an ocean of ideas Marinomed Biotech AG is an Austrian, science-driven biotech company with a growing development pipeline and globally marketed therapeutics. The Company focuses on the development of innovative, patent-protected products in the therapeutic areas of respiratory and ophthalmic diseases, based on the proprietary Marinosolv® platform. The Marinosolv® technology significantly improves the solubility and bioavailability of hardly soluble compounds, enabling the development of novel therapies for immune-related and inflammatory disorders. Under the brand Solv4U Marinomed offers drug development in all stages, based on its patent protected Marinosolv® technology platform. The Company’s Carragelose®-based OTC …

59 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

The Protein Design Company (TM) - new proteins and biochemistry for the production of valuable sustainable molecules Arzeda, The Protein Design CompanyTM, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications. More information at www.arzeda.com. Synthetic Biology, Bio-based Chemicals, and Protein Design

132 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Wo es für andere schwierig wird, da fängt es für uns an. Develco Pharma is a privately owned company operating in the field of development and manufacture of pharmaceutical products. We develop and produce difficult to make, innovative formulations of drugs, with the goal to improve quality of life and success of the company. Special release formulations, once daily, narcotics, MUPS, pragmatic development, and flexible manufacturing

107 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology